Monocytic Leukemia
📧 Sign up to get email alerts when something new happens for Monocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML [Phase 2]
Phase 2 clinical trial evaluating venetoclax in combination with cladribine and cytarabine alternating with azacitidine plus venetoclax for …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial evaluating the combination of decitabine, cytarabine, and daunorubicin hydrochloride for treatment of Acute Myeloid…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating venetoclax in combination with a CACAG regimen versus the 3+7 regimen for acute monocytic leukemia is cu…
-
CLINICAL_TRIALS other · 2026-03-23Clinical Trial Update: Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study [Phase 2]
Clinical trial HALTAging-1 is a Phase 2 study targeting aging in survivors of blood cancers; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Cladribine Venetoclax in Monocytic AML [Phase 2]
A Phase 2 clinical trial evaluating the combination of cladribine and venetoclax for monocytic acute myeloid leukemia, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia [Phase 2]
A Phase 2 clinical trial is evaluating the triple combination of venetoclax, azacitidine, and chidamide (VAC) for newly diagnosed acute mono…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Integrated Actionable Aging Assessment for Cancer Patients Pilot [NA]
This entry summarizes a pilot trial from University of Colorado, Denver to develop an integrated aging assessment for cancer patients; the s…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [EARLY_Phase 1]
A Phase 1 trial evaluating a combination of sirolimus, idarubicin, and cytarabine in adults with newly diagnosed acute myeloid leukemia has …
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia [Phase 1]
This Phase 1 trial evaluated FT538 in combination with daratumumab in acute myeloid leukemia, including monocytic leukemia, and has complete…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients [Phase 2]
Phase 2 trial update on intravenous vitamin C use in allogeneic stem cell transplant recipients, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children [Phase 2, Phase 3]
Clinical trial update for treatment of newly diagnosed acute monocytic leukemia in children, currently in Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: AML Therapy With Irradiated Allogeneic Cells [NA]
Clinical trial update for irradiated allogeneic cell therapy in various adult acute myeloid leukemia subtypes; the study is terminated with …
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating a MEK inhibitor (MEK162) in combination with idarubicin and cytarabine for adults with relapsed or refractory acu…
-
CLINICAL_TRIALS withdrawal · 2017-10-19Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission [Phase 2]
A Phase 2 trial evaluating donor stem cell transplant for adults with acute myeloid leukemia in remission has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay [NA]
Clinical trial update on using a high-throughput drug sensitivity assay to guide treatment for relapsed/refractory acute myeloid leukemia.
-
CLINICAL_TRIALS withdrawal · 2017-04-05Clinical Trial Update: A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia [Phase 1]
Phase 1 study of volasertib plus induction chemotherapy for acute myeloid leukemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS [Phase 2]
Phase 2 clinical trial evaluated a sequence of decitabine followed by idarubicin and cytarabine in adults with relapsed or refractory acute …
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update of ixazomib in relapsed or refractory acute myeloid leukemia has been terminated; results were posted previous…
-
CLINICAL_TRIALS research · 2016-05-19Clinical Trial Update: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
A completed pediatric AML biomarker study update from the Children's Oncology Group examining biomarkers in bone marrow from high-risk AML p…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating a three-drug regimen of omacetaxine mepesuccinate, cytarabine, and decitabine in older adults with newly diagnosed …
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy [Phase 2]
Phase 2 trial evaluating cholecalciferol (Vitamin D3) in adults with acute myeloid leukemia undergoing intensive induction chemotherapy; the…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating AKT inhibitor MK-2206 in relapsed or refractory adult acute leukemias completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating bortezomib in combination with chemotherapy for younger patients with recurrent, refractory, or secondary acute m…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of entinostat and sorafenib in patients with advanced or metastatic solid tumors or relapsed/refr…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 3]
Phase 3 trial evaluating whether adding the P-glycoprotein modulator valspodar to standard chemotherapy improves outcomes in adults with pre…